TaiGen Enters Exclusive License Agreement with YSP
TAIPEI, Oct. 11, 2023 /PRNewswire/ — TaiGen Biopharmaceuticals Holdings Ltd. ("TaiGen") announces that TaiGen Biotechnology, a subsidiary company of TaiGen, have signed an exclusive licensing agreement with Y.S.P. Industries (M) Sdn. Bhd. to develop and commercialize TaiGen’s new drug in Malaysia and Singapore. TaiGen indicates that the agreement involves the development and marketing rights of the […]